EVOTEC SE - SPON ADR (EVO)

US30050E1055 - ADR

5.25  +0.06 (+1.16%)

After market: 5.2 -0.05 (-0.95%)

News Image
8 days ago - InvestorPlace

Why Is Fabrinet (FN) Stock Down Today?

Fabrinet stock is falling on Wednesday after the company provided FN investors with a date for its upcoming earnings report.

News Image
8 days ago - InvestorPlace

Why Is Evotec (EVO) Stock Down 33% Today?

Evotec stock is falling on Wednesday as EVO investors react to a lackluster 2024 revenue guidance in its 2023 earnings results.

News Image
8 days ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

We are starting off Wednesday with a breakdown of the biggest pre-market stock movers traders will want to read about this morning!

News Image
14 days ago - Variant Bio, Inc.

EVOTEC AND VARIANT BIO ENTER STRATEGIC PARTNERSHIP TO DISCOVER AND DEVELOP FIBROSIS TREATMENTS

/PRNewswire/ -- Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and Variant Bio, Inc. today announced a collaboration...

News Image
a month ago - InvestorPlace

Finding the Next Big Winners: 7 Stocks You Can Snag for Under $10

Looking for stocks under $10? Here are seven great bargain picks that you can buy for less than $10 per share today.

News Image
2 months ago - InvestorPlace

3 Stocks Set to Double: Your Fast Track to 2024 Gains

Looking for bargains in the market right now? These three stocks could be set to double in coming months.

News Image
2 months ago - InvestorPlace

7 Stable Stocks to Buy for 100% Returns by 2025

If you're looking for stability and the opportunity to double your returns by the time 2025 rolls around, check out these stable stocks.

News Image
3 months ago - InvestorPlace

The Next Johnson & Johnson? 3 Healthcare Stocks That Investors Shouldn’t Ignore.

Looking for the next generational winner in healthcare stocks? These are three of the top prospects today.

News Image
4 months ago - InvestorPlace

Why Is Mobileye (MBLY) Stock Down 26% Today?

Mobileye stock is taking a beating on Thursday with investors in MBLY bemoaning the company's revenue outlook for the year.

News Image
4 months ago - InvestorPlace

Can TikTok Save Peloton (PTON) Stock?

Peloton stock is heading higher on Thursday as investors in PTON react to the company signing a new partnership with TikTok.

News Image
4 months ago - InvestorPlace

Why Is Evotec (EVO) Stock Down 12% Today?

Evotec stock is falling on Thursday with heavy trading of EVO shares following the resignation of the company's CEO, Dr. Werner Lanthaler.

News Image
4 months ago - InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

Pre-market stock movers are a hot topic this morning as we cover all of the biggest market news traders need to know about on Thursday!

News Image
4 months ago - Seeking Alpha

Evotec and Owkin enter AI-powered partnership (NASDAQ:EVO)

Evotec and Owkin join forces in an A.I.-powered strategic partnership to advance drug development activities in oncology, immunology, and inflammation.

News Image
5 months ago - Seeking Alpha

Evotec partner Jingxin receives approval for EVT201 in China (NASDAQ:EVO)

Evotec's partner, Zhejiang Jingxin Pharmaceutical, receives approval for insomnia treatment EVT201 in China, paving the way for further development and...

News Image
6 months ago - Seeking Alpha

Evotec SE reports 9M results (NASDAQ:EVO)

Evotec press release (EVO): 9M Adjusted EBITDA of €50.2M Revenues increased by 14% Y/Y to €580.1M

News Image
8 months ago - Seeking Alpha

Evotec SE reports 1H results; updates FY23 guidance (NASDAQ:EVO)

Evotec SE press release (EVO): 1H adjusted Group EBITDA totalled €26.1M (H1 2022: €33.6M).Revenue of €383.8M (+13.9% Y/Y).Outlook: Group revenues expected to be in a range of € 750 - 790...

News Image
10 months ago - Seeking Alpha

Bristol Myers in licenses under Evotec neuroscience deal (NASDAQ:EVO)

Evotec (EVO) announced Tuesday Bristol Myers Squibb (BMY) entered into a licensing agreement under the companies' partnership on neurodegeneration. Read more here.